Wait...
Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Date: 01-02-2025
Notification No: Notification No. 09/2025-Customs
Issuing Authority: Indian Customs  
Type: Tariff
File No: [F. No. 334/03/2025-TRU]
Subject: Seeks to further amend notification No. 16/2017-Customs, dated the 20 th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified pharmaceutical companies.
Untitled 1

[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II, SECTION 3,
SUB-SECTION (i)]
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(Department of Revenue)
Notification No. 09/2025-Customs
New Delhi, the 1st February, 2025

 G.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,
1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do,
hereby makes the following further amendments in the notification of the Government of India in the Ministry of
Finance (Department of Revenue) No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of
India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 394(E), dated the 20th April, 2017,
namely :-

In the said notification, in the TABLE, after serial number 52 and the entries relating thereto, the following
serial numbers and the entries shall be inserted, namely :-

(1) (2) (3) (4)
“53. Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals
54. Pembrolizumab KIRAN MSD KIRAN MSD Pharmaceuticals
55 Lorlatinib LorbriquaCare LorbriquaCare Pfizer Products India Private Ltd.
56 Dacomitinib  DacoCare Pfizer Products India Private Ltd.
57 Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd
58 Ribociclib UMAANG Novartis Healthcare Pvt. Ltd.
59 Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd.
60 Selumetinib AstraZeneca Pharma AstraZeneca Pharma India Limited
61 Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
62 Fulvestrant AstraZeneca Pharma AstraZeneca Pharma India Limited
63 Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
64 Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
65 Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
66 Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
67 Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
68 Daratumumab
And hyaluronidase-fihj
Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
69 Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
70 Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
71 Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
72 Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd.
73 Avelumab My Bavencio Assist Program Merck Specialties Pvt. Ltd.
74 Tepotinib My Tepmetko Patient Access
Program
Merck Specialties Pvt. Ltd.
75 Brentuximab Vedotin Takeda PAP Biopharmaceuticals India Pvt.
Limited
76 Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
77 Velaglucerase Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
78 Agalsidase Alpha Takeda PAP Biopharmaceuticals India Pvt.
Limited
79 Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
80 Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited
81 Alectinib The Blue Tree Roche Products India Private Ltd.
82 Risdiplam Powder The Blue Tree Roche Products India Private Ltd.
83 Emicizumab The Blue Tree Roche Products India Private Ltd.
84 Atezolizumab The Blue Tree Products India Private Ltd.
85 Pertuzumab +
trastuzumab
The Blue Tree Products India Private Ltd.
86 Ocrelizumab The Blue Tree Roche Products India Private Ltd.
87 Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd.
88 Faricimab The Blue Tree Roche Products India Private Ltd
89 Luspatercept Bristol-Myers Patient Assistance
Program
Bristol-Myers Squibb India Pvt. Ltd. ”

  
  2. This notification shall come into force on the 2nd day of February, 2025.

[F. No. 334/03/2025-TRU]
(Amreeta Titus)
Deputy Secretary to the Government of India

Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017 was published in the Gazette of
India, Extraordinary, Part II, Section 3, Sub-Section (i), vide number G.S.R. 394(E), dated the 30th June, 2017.  

       

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 03-02-2025
[F. No. CBIC-190354/236/2021-TRU]
Corrigendum to Notification No. 50 of 2024 Customs, dated the 30th December, 2024.

Date: 01-02-2025
Notification No. 13/2025-Customs
Seeks to further amend notification No. 153/94-Customs dated the 13 th July, 1994.

Date: 01-02-2025
Notification No. 12/2025-Customs
Seeks to further amend notification No. 19/2019 dated 06 th July 2019.

Date: 01-02-2025
Notification No. 11/2025 – Customs
Seeks to further amend notification No. 25/2002-Customs, dated the 1st March, 2002 so as to add capital goods to the already existing list of capital goods exempted from basic customs duty for manufacture of lithium-ion battery of mobile phones and electrically operated vehicles.

Date: 01-02-2025
Notification No. 09/2025-Customs
Seeks to further amend notification No. 16/2017-Customs, dated the 20 th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified pharmaceutical companies.

Date: 01-02-2025
Notification No. 04/2025–Customs
Seeks to exempt the import duty on goods which are being rationalized in the tariff.

Date: 01-02-2025
Notification No. 03/2025-Customs
Seeks to further amend notification No. 27/2011-Customs dated 30 th June, 2017 so as to reduce the export duty on crust leather.

Date: 01-02-2025
Notification No. 10/2025 – Customs
Seeks to further amend notification No. 57/2017 dated 30 th June, 2017 so as to change BCD rates on inputs/parts used for manufacture of parts of cellular mobile phones along with other high technology telecom equipments.

Date: 23-01-2025
NOTIFICATION NO. 08/2025 – CENTRAL TAX
Central Tax Notification for waiver of the late fee

Date: 16-01-2025
Notification No. 03/2025- Central Tax (Rate)
Seeks to amend Notification no. 39/2017- Central Tax (Rate)



Exim Guru Copyright © 1999-2025 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001